Suppr超能文献

腺相关病毒介导的癌症基因治疗:现状

Adeno-associated virus-mediated cancer gene therapy: current status.

作者信息

Luo Jingfeng, Luo Yuxuan, Sun Jihong, Zhou Yurong, Zhang Yajing, Yang Xiaoming

机构信息

Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Qingchun Road NO.3, Hangzhou, Zhejiang, China.

Department of Nephrology, Zhuji People's Hospital, Zhuji, Zhejiang, China.

出版信息

Cancer Lett. 2015 Jan 28;356(2 Pt B):347-56. doi: 10.1016/j.canlet.2014.10.045. Epub 2014 Nov 10.

Abstract

Gene therapy is one of the frontiers of modern medicine. Adeno-associated virus (AAV)-mediated gene therapy is becoming a promising approach to treat a variety of diseases and cancers. AAV-mediated cancer gene therapies have rapidly advanced due to their superiority to other gene-carrying vectors, such as the lack of pathogenicity, the ability to transfect both dividing and non-dividing cells, low host immune response, and long-term expression. This article reviews and provides up to date knowledge on AAV-mediated cancer gene therapy.

摘要

基因治疗是现代医学的前沿领域之一。腺相关病毒(AAV)介导的基因治疗正成为治疗多种疾病和癌症的一种有前景的方法。由于AAV介导的癌症基因治疗相对于其他基因载体具有优势,如无致病性、能够转染分裂细胞和非分裂细胞、宿主免疫反应低以及长期表达,因此其发展迅速。本文回顾并提供了关于AAV介导的癌症基因治疗的最新知识。

相似文献

1
Adeno-associated virus-mediated cancer gene therapy: current status.
Cancer Lett. 2015 Jan 28;356(2 Pt B):347-56. doi: 10.1016/j.canlet.2014.10.045. Epub 2014 Nov 10.
2
Cancer gene therapy using adeno-associated virus vectors.
Front Biosci. 2008 Jan 1;13:2653-9. doi: 10.2741/2872.
3
Vectrology of adeno-associated viruses (AAV).
Med Wieku Rozwoj. 2013 Jul-Sep;17(3):202-6.
5
Adeno-associated virus vectors: potential applications for cancer gene therapy.
Cancer Gene Ther. 2005 Dec;12(12):913-25. doi: 10.1038/sj.cgt.7700876.
6
Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
Cancer Lett. 2009 Dec 28;286(2):196-205. doi: 10.1016/j.canlet.2009.05.024. Epub 2009 Jun 28.
7
Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
Arch Oral Biol. 2011 Jul;56(7):619-28. doi: 10.1016/j.archoralbio.2010.12.010. Epub 2011 Feb 26.
8
Gene therapy using adeno-associated virus vectors.
Clin Microbiol Rev. 2008 Oct;21(4):583-93. doi: 10.1128/CMR.00008-08.
9
Viral vector-mediated gene therapies.
Curr Opin Neurol. 2015 Oct;28(5):522-7. doi: 10.1097/WCO.0000000000000241.

引用本文的文献

2
Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma.
ACS Omega. 2024 Jul 3;9(28):30945-30953. doi: 10.1021/acsomega.4c03949. eCollection 2024 Jul 16.
4
CRISPR/Cas9: an overview of recent developments and applications in cancer research.
Int J Surg. 2024 Oct 1;110(10):6198-6213. doi: 10.1097/JS9.0000000000001081.
5
Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer.
Mol Ther Methods Clin Dev. 2023 Nov 24;31:101166. doi: 10.1016/j.omtm.2023.101166. eCollection 2023 Dec 14.
6
Engineering siRNA therapeutics: challenges and strategies.
J Nanobiotechnology. 2023 Oct 18;21(1):381. doi: 10.1186/s12951-023-02147-z.
7
A dual role for adeno-associated virus in human health.
Virol J. 2023 Oct 10;20(1):228. doi: 10.1186/s12985-023-02196-8.
8
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine.
Genes Dis. 2023 Mar 25;11(1):268-282. doi: 10.1016/j.gendis.2023.02.027. eCollection 2024 Jan.
9
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview.
Cells. 2023 Mar 1;12(5):785. doi: 10.3390/cells12050785.
10
Adding recombinant AAVs to the cancer therapeutics mix.
Mol Ther Oncolytics. 2022 Oct 2;27:73-88. doi: 10.1016/j.omto.2022.09.009. eCollection 2022 Dec 15.

本文引用的文献

2
Ibrutinib resistance in chronic lymphocytic leukemia.
N Engl J Med. 2014 Jun 12;370(24):2352-4. doi: 10.1056/NEJMc1402716. Epub 2014 May 28.
3
Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected mice.
PLoS One. 2014 May 27;9(5):e98496. doi: 10.1371/journal.pone.0098496. eCollection 2014.
4
Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.
Mol Ther. 2014 Aug;22(8):1450-1459. doi: 10.1038/mt.2014.84. Epub 2014 May 12.
6
Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications.
Mol Neurobiol. 2015 Feb;51(1):43-56. doi: 10.1007/s12035-014-8691-z. Epub 2014 Apr 15.
8
Overcoming drug resistance in ALK-rearranged lung cancer.
N Engl J Med. 2014 Mar 27;370(13):1250-1. doi: 10.1056/NEJMe1316173.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验